Subscribe: Market Wire - Medical and Healthcare: Medical Devices
http://img.marketwire.com/rss/mwMHMD.rss
Added By: Feedage Forager Feedage Grade B rated
Language: English
Tags:
cancer  company  conference lung  cáncer pulmón  december  iaslc  lung cancer  lung  marketwired december  marketwired  wclc 
Rate this Feed
Rate this feedRate this feedRate this feedRate this feedRate this feed
Rate this feed 1 starRate this feed 2 starRate this feed 3 starRate this feed 4 starRate this feed 5 star

Comments (0)

Feed Details and Statistics Feed Statistics
Preview: Market Wire - Medical and Healthcare: Medical Devices

Marketwired - Medical Devices



Marketwired - Medical Devices



Last Build Date: Fri, 09 Dec 2016 09:31:40 EST

Copyright: Copyright: (C) Marketwired
 



ListenTrust Answered Over 44,000 Donation Calls During the 30-Hour 2016 TeletonUSA Fundraising Event

Fri, 09 Dec 2016 08:04:00 EST

English and Spanish Language Call Center Supported Nonprofit Partner During Live National Event Aired on Univision




PolarityTE(TM) Inc., names World Renowned Plastic & Reconstructive Surgeon Michael W. Neumeister, MD, FRCSC, FACS, as Chief Medical Officer

Fri, 09 Dec 2016 08:00:00 EST

Dr. Neumeister has previously served as President of the Plastic Surgery Foundation, Plastic Surgery Research Council and a Leader in Translational Regenerative Medicine




3D Signatures Appoints Two Industry Specialists to Board Positions

Fri, 09 Dec 2016 07:00:00 EST

WINNIPEG, MB--(Marketwired - December 09, 2016) - 3D Signatures Inc. (TSX VENTURE: DXD) (the "Company" or "3DS") is pleased to announce two additional strategic appointments to its Board of Directors and its Clinical and Scientific Advisory Board respectively. Helen Stevenson, Founder and Chief Executive Officer of Reformulary Group Inc., has been appointed to the Company's Board of Directors. Dr. Ian Smith, will be stepping down from the Board of Directors and will be joining the Company's Clinical and Scientific Advisory Board ("CSAB"). Both appointments will help shape 3DS' clinical priorities and its path towards commercial success.




Pacific Safety Products Inc. Provides Update on Unsolicited Offer of $0.25 Per Share from MKU Limited

Thu, 08 Dec 2016 18:24:29 EST

ARNPRIOR, ONTARIO--(Marketwired - Dec. 8, 2016) - Pacific Safety Products Inc. ("PSP" or the "Company") (TSX VENTURE:PSP), a leading North American manufacturer of advanced armour and personal protection solutions, would like to update its shareholders on the unsolicited offer received from an affiliate of MKU Limited ("MKU") to acquire all of the outstanding common shares of PSP, including those issuable upon conversion of PSP's outstanding convertible debentures, for $0.25 in cash per share (the "MKU Offer") announced on December 5, 2016.




Southern Home Medical Inc. Announces Clarification of Press Release Dated December 1, 2016

Thu, 08 Dec 2016 17:53:55 EST

NEW YORK, NY--(Marketwired - Dec 8, 2016) - Southern Home Medical Inc. (OTC PINK: SHOM), a leading developer in the Healthcare Industry, announced that it is issuing this news release to clarify the information contained in its news release titled "Southern Home Medical Inc. Subsidiary signs a Testing Contract with Coca-Cola East Japan" dated December 1, 2016. 




Zywie Receives the Two Top Awards for Innovation at Health IT Leadership Summit

Thu, 08 Dec 2016 15:58:29 EST

Next-Generation Remote Cardiac Monitoring Solution Revolutionizing Decades-Old Solution




Milestone Scientific, Inc. Reports Progress Related to its Exclusive Distribution Agreement with Henry Schein, Inc.

Thu, 08 Dec 2016 12:48:24 EST

Henry Schein Ahead of Schedule in Training its Exclusive Products Sales Specialists on The Wand(R) STA Single Tooth Anesthesia System(R) Instrument




CORRECTION: Emblem Corp. to Trade Under Symbol "EMC"

Thu, 08 Dec 2016 11:45:07 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 8, 2016) -




Denise Hines Receives Phoenix Award for Community Leadership

Thu, 08 Dec 2016 10:42:25 EST

ATLANTA, GA--(Marketwired - Dec 8, 2016) - Denise Hines, DHA, PMP, FHIMSS, CEO of eHealth Services Group and Executive Director of Georgia Health Information Network (GaHIN), received the Phoenix Community Leader of the Year Award at the 2016 Health IT Leadership Summit. Dr. Hines was recognized for her instrumental role in advancing healthcare connectivity in Georgia to ensure physicians have the information they need to deliver quality care.




DWFritz Releases First Automated Seal Inspection System for Medical Manufacturing

Thu, 08 Dec 2016 09:00:00 EST

The custom-made machine will be used to verify the package integrity of sterile medical devices and supplies




The Life Sciences Report Examines Reliq Health Technologies' Remote Patient Monitoring Pilot Program

Thu, 08 Dec 2016 09:00:00 EST

SAN FRANCISCO, CA--(Marketwired - December 08, 2016) - Reliq Health Technologies Inc. (TSX VENTURE: RHT) is initiating a trial of its remote patient monitoring system with The Feldman Institute in Louisiana, the fourth program for the company's innovative technology.




Functional Prototype Complete -- Imagin Medical Chooses Optel to Design i/Blue Prototype for Commercialization

Thu, 08 Dec 2016 08:00:00 EST

Imagin Medical Is the Developer of the Ultrasensitive i/Blue Imaging System That Will Establish a New Standard of Care for Urologists in Detecting Bladder Cancer Through Endoscopes




Digital Marketing and Direct-to-Consumer Advertising is a Growing Component in the Pharma Industry

Thu, 08 Dec 2016 07:53:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - December 08, 2016) - Contrary to initial misgivings about digital and social channels, they have become an increasingly popular part of healthcare companies' marketing mixes, according to research from Cutting Edge Information.




Exosome Diagnostics Announces the First Instrument for Point of Care Liquid Biopsy

Thu, 08 Dec 2016 07:30:00 EST

CAMBRIDGE, MA--(Marketwired - December 08, 2016) - Exosome Diagnostics, Inc. announced today that it has developed the first instrument for exosomal protein (exoProtein) capture and analysis directly from any biofluid. The capabilities of this system will revolutionize drug development and point of care diagnostics using liquid biopsy.




Das Pressebriefing der 17. IASLC WCLC zeigt Fortschritte bei der Lungenkrebsbehandlung durch Immuntherapie und eine verbesserte Diagnostik

Thu, 08 Dec 2016 06:45:46 EST

WIEN, ÖSTERREICH --(Marketwired - 8. Dezember 2016) - Das heutige Pressebriefing auf der 17. IASLC (International Association for the Study of Lung Cancer) World Conference on Lung Cancer(WCLC) konzentrierte sich auf klinische Studien, die den Fortschritt bei der Behandlung von Lungenkrebs durch Immuntherapie und eine bessere Diagnostik beschleunigen. Abstracts und vollständige Versionen von Pressemitteilungen für jedes Thema sind über Links in dieser Zusammenfassung oder über den Pressevertreter der IASLC, Chris Martin, auf cmartin@davidjamesgroup.com verfügbar.




Le point-presse de la 17e WCLC de l'IASLC révèle des avancées dans le traitement du cancer du poumon grâce à l'immunothérapie et à de meilleurs diagnostics

Thu, 08 Dec 2016 00:23:47 EST

VIENNE, AUTRICHE--(Marketwired - 8 décembre 2016) - Le point-presse d'aujourd'hui à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC s'est concentré sur des essais cliniques qui font progresser le traitement du cancer du poumon grâce à l'immunothérapie et à de meilleurs diagnostics. Des résumés et des versions complètes des communiqués de presse pour chaque thème couvert sont disponibles via les liens fournis dans ce résumé, ou auprès de Chris Martin, représentant de l'IASLC auprès des médias, à l'adresse : cmartin@davidjamesgroup.com.




Emblem Corp. Announces Completion of Qualifying Transaction, Short Form Offering and Proposed Private Placement

Wed, 07 Dec 2016 23:54:32 EST

VANCOUVER, BRITISH COLUMBIA--(Marketwired - Dec. 7, 2016) -




EPIC, The Dividend Company, Is Developing Joint Ventures With Medical Device Companies, and Announces the Fifteenth Quarterly Stock Dividend

Wed, 07 Dec 2016 23:30:00 EST

AUSTIN, TX--(Marketwired - December 07, 2016) - EPIC Corporation (OTC PINK: EPOR) ("EPIC" or "Company") and Ronald S. Tucker announced, "EPIC has, within the last several months, identified and made contact with more than 10 development stage Medical Device companies which has helped to refine the 'EPIC Process,' and EPIC announced its 15th consecutive quarterly dividend of common stock payable to preferred stockholders."




Rueda de prensa de la 17ª WCLC de la IASLC revela avances en el tratamiento del cáncer de pulmón gracias a la inmunoterapia y a mejores diagnósticos

Wed, 07 Dec 2016 21:11:45 EST

VIENA, AUSTRIA--(Marketwired - 7 de diciembre de 2016) - La rueda de prensa de hoy de la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) de la IASLC se centró en ensayos clínicos que impulsan el progreso logrado en el tratamiento del cáncer de pulmón a través de la inmunoterapia y de mejores diagnósticos. Los resúmenes y las versiones completas de los comunicados de prensa de cada tema cubierto están disponibles a través de los enlaces en este resumen, o a través del representante de medios de la IASLC, Chris Martin, en cmartin@davidjamesgroup.com.




Die regelmäßige Anwendung von Ibuprofen könnte das Lungenkrebsrisiko bei hochgefährdeten Untergruppen von Zigarettenrauchern senken

Wed, 07 Dec 2016 19:19:45 EST

WIEN, ÖSTERREICH--(Marketwired - 7. Dezember 2016) - Laut den während der von der IASLC in Wien (Österreich) veranstalteten 17. Weltlungenkrebskonferenz (WCLC) präsentierten Forschungsergebnissen könnte die regelmäßige Anwendung von Ibuprofen das Lungenkrebsrisiko von Personen mit einer Rauchervergangenheit senken.




L'usage régulier de l'ibuprofène réduirait les risques de cancer du poumon chez les sous-catégories de fumeurs de cigarettes à risque élevé

Wed, 07 Dec 2016 19:13:15 EST

VIENNE, AUTRICHE--(Marketwired - 7 décembre 2016) - La consommation régulière d'ibuprofène permettrait de réduire les risques de cancer du poumon chez les patients ayant des antécédents d'usage de la cigarette ; telles sont les conclusions qui ressortent d'une étude présentée lors de la 17ème Conférence mondiale sur le cancer du poumon(WCLC) organisée par l'IASLC à Vienne (Autriche).




Coletiva com a mídia do IASLC 17th WCLC revela os avanços no tratamento de câncer de pulmão por meio da imunoterapia e melhores diagnósticos

Wed, 07 Dec 2016 17:29:22 EST

VIENNA, AUSTRIA--(Marketwired - 7 de dezembro de 2016) - A coletiva com a mídia de hoje da IASLC 17th World Conference on Lung Cancer(Conferência Mundial de Câncer de Pulmão -WCLC) concentrou-se no testes clínicos que avançam o progresso do tratamento de câncer de pulmão por meio da imunoterapia e melhores diagnósticos. Abstratos e versões completas dos releases de cada tópico estão disponíveis nos links deste resumo, ou com Chris Martin, representante de mídia da IASLC no cmartin@davidjamesgroup.com.




El uso regular de Ibuprofen puede reducir el riesgo de cáncer de pulmón entre los subgrupos de fumadores de cigarrillo de alto riesgo

Wed, 07 Dec 2016 17:11:22 EST

VIENNA, AUSTRIA--(Marketwired - 7 de diciembre de 2016) - El uso regular de ibuprofeno puede reducir el riesgo de cáncer de pulmón entre las personas con historia de haber fumado cigarrillo, según una investigación presentada en la 17ava. Conferencia Mundial sobre el Cáncer de Pulmón(WCLC) de la Asociación Internacional para el Estudio del Cáncer de Pulmón (IASLC) en Viena, Austria.




Uso regular de ibuprofeno pode reduzir o risco de Câncer de Pulmão nos subgrupos de alto risco dos fumantes de cigarro

Wed, 07 Dec 2016 15:19:28 EST

VIENNA, AUSTRIA--(Marketwired - 7 de dezembro de 2016) - O uso regular de ibuprofeno pode reduzir o risco do câncer de pulmão dos fumantes de cigarro, de acordo com a pesquisa apresentada na IASLC 17th World Conference on Lung Cancer(Conferência Mundial sobre o Câncer de Pulmão - WCLC) em Viena, Áustria.




Senate Passes Landmark 21st Century Cures Act

Wed, 07 Dec 2016 15:16:05 EST

WASHINGTON, DC--(Marketwired - December 07, 2016) - Today, the United States Senate overwhelmingly approved the 21st Century Cures Act, a game-changer for medical innovation, by a bipartisan vote of 94-5. The President is expected to sign the bill into law later this week.




NextGate Releases Latest Update to iDAS

Wed, 07 Dec 2016 15:08:08 EST

The updated iDAS (the intelligent Data Aggregation Server) platform delivers new capabilities to automatically link together patient and provider data, a centralized monitoring system and expanded data models




Revenues from Nickel Alloys for Additive Manufacturing to Grow to $520 Million by 2026, according to New SmarTech Publishing Report

Wed, 07 Dec 2016 13:34:04 EST

CHARLOTTESVILLE, VA--(Marketwired - December 07, 2016) - Two major metals suppliers -- ATI Metals and Arconic -- have recently announced their intent to increase their capacity and focus on nickel based additive manufacturing. Meanwhile the market for nickel-based powders used in AM processes will grow from an estimated $28 million worldwide in 2015 to over $520M by 2026, according to a new report from SmarTech Publishing -- the leading provider of market intelligence and forecasts for the additive manufacturing/3D printing sector.




DePuy Synthes, Stryker Lead Orthopedic Trauma Device Market Driven by Influx of High Cost New Technology, According to iData Research

Wed, 07 Dec 2016 12:36:45 EST

There are over 1.8 million total trauma fixation procedures performed in the United States so far this year, as a result, the orthopedic trauma device market is expected to reach over $4 billion by 2023




Proove Biosciences Unveils First Precision Medicine Genetic Test for Painful TMJ Disorder

Wed, 07 Dec 2016 12:00:00 EST

Proove Launches the Only Commercially Available Genetic Analysis Offering Personalized Medical Treatment Recommendations for TMD Sufferers and Insights Into Contributing Causes of Orofacial Pain




Independence Blue Cross Foundation announces grants supporting community health and well-being

Wed, 07 Dec 2016 12:00:00 EST

Nearly $3.1 million in funding supports community health clinics, efforts to increase survival rates for sudden cardiac arrest, and initiatives that build healthier communities




DirectTrust Directory Service Reaches Critical Mass as Directory Surpasses Half a Million Entries

Wed, 07 Dec 2016 09:23:15 EST

Directory Service enables hassle-free interoperability for Direct exchange users




Acquisitions are In-Vogue for Largest Medical Device Manufacturers

Wed, 07 Dec 2016 09:09:00 EST

Breakdown of Medical Device Acquisitions Reveals Industry Strategy




SYSPRO Canada Sponsors Inaugural Industry Report on the Export Practices of Canadian Manufacturers

Wed, 07 Dec 2016 09:00:00 EST

The report benchmarks manufacturers' current export business and illuminates their challenges, success strategies and plans for growth in overseas markets




GeoVax to Conduct Investor and Partnering Meetings During 35th Annual J.P. Morgan Healthcare Conference

Wed, 07 Dec 2016 09:00:00 EST

ATLANTA, GA--(Marketwired - Dec 7, 2016) -  GeoVax Labs, Inc. (OTCQB: GOVX), a biotechnology company developing human vaccines, announced today that it is scheduling investor and corporate partnering meetings during the 35th Annual J.P. Morgan Healthcare Conference, to be held in San Francisco on January 9-12, 2017.




Model N Announces the Winter '16-17 Release, Transforming its Revenue Management Solutions for High Tech

Wed, 07 Dec 2016 09:00:00 EST

Channel Data Management Now Integrates with Revenue Enterprise Cloud to Enhance Data Collection Processes, Price More Effectively and Drive Long Term Revenue




IASLC 17th WCLC Press Briefing Reveals Advancements in Lung Cancer Treatment Through Immunotherapy and Better Diagnostics

Wed, 07 Dec 2016 09:00:00 EST

VIENNA, AUSTRIA--(Marketwired - December 07, 2016) - Today's press briefing at the IASLC 17th World Conference on Lung Cancer (WCLC) focused on clinical trials that advance the progress made in lung cancer treatment through immunotherapy and better diagnostics. Abstracts and full versions of news releases for each topic covered are available through links in this summary, or through IASLC media representative Chris Martin at cmartin@davidjamesgroup.com.




Image Protect Inc. Engages the largest Stock Photo Marijuana Site for Copyright Infringements

Wed, 07 Dec 2016 08:39:59 EST

SAN CLEMENTE, CA--(Marketwired - Dec 7, 2016) - Image Protect Inc. (OTC: IMTL)




Centralized Adaptive Trial Design Teams Promote Cross-Geography Communication

Wed, 07 Dec 2016 08:36:00 EST

RESEARCH TRIANGLE PARK, NC--(Marketwired - December 07, 2016) - A recent study released by Cutting Edge Information found that most surveyed clinical trial teams -- either global or at the country level -- report better cross-geography communication through centralized adaptive trial design decision-making structures. Establishing these centralized structures helps influence active dialogue between global and country-level teams.




Stealth Mark Opens Office in Silicon Valley to Support Tech Companies with Its Anti-Counterfeiting Technology

Wed, 07 Dec 2016 08:00:00 EST

Key Executive Retained to Expand Business Development Efforts With Top Tier Technology Companies in Silicon Valley




Regular Use of Ibuprofen May Lower Lung Cancer Risk Among High-Risk Subgroups of Cigarette Smokers

Wed, 07 Dec 2016 08:00:00 EST

VIENNA, AUSTRIA--(Marketwired - December 07, 2016) - Regular use of ibuprofen may lower the risk of lung cancer among those with a history of cigarette smoking, according to research presented at the IASLC 17th World Conference on Lung Cancer (WCLC) in Vienna, Austria.




DiaMedica Expands its Business Development Capabilities

Wed, 07 Dec 2016 08:00:00 EST

MINNEAPOLIS, MINNESOTA--(Marketwired - Dec. 7, 2016) - DiaMedica Inc. (the "Company") (TSX VENTURE:DMA)(OTCQB:DMCAF) announced today it has engaged Outreach 99 LLC ("Outreach") to assist in the business development efforts of the Company. Paul Papi, Founder and President of Outreach 99 LLC, will personally direct the effort, acting as DiaMedica's Vice President of Business Development.




Capsa Expands Popular 'Vintage Series' Medication Cart Line for LTC

Wed, 07 Dec 2016 07:00:00 EST

PORTLAND, OR--(Marketwired - December 07, 2016) - Capsa Solutions ("Capsa"), a leading provider of medication management systems, pharmacy automation, and mobile computing carts to the healthcare industry, today announced it has expanded its popular Vintage Series Medication Carts and Cabinets line for long-term care and assisted living facilities.




3D Signatures Molecular Imaging Technology Shows Potential in Improving Management of Lung Cancer Patients With Multiple Lesions

Wed, 07 Dec 2016 07:00:00 EST

Preliminary results of an important collaborative initiative with IUCPQ presented at 17th World Conference on Lung Cancer (WCLC) in Vienna, Austria




ITUS Announces Cchek(TM) Preliminary Cancer Patient Efficacy Study Results

Wed, 07 Dec 2016 06:45:00 EST

LOS ANGELES, CA--(Marketwired - December 07, 2016) - ITUS Corporation ("ITUS") (NASDAQ: ITUS), today announced preliminary results from its CchekT cancer patient efficacy study. Using its most recent protocols and methods for measuring a patient's immunological response to a malignancy, the Company achieved Sensitivity of 92% and Specificity of 92% for 88 patient samples, including 54 samples from patients with multiple types and severities of cancer, and 34 healthy patients. During the initial phase of the study, which involved multiple experimental protocols and techniques for measuring immunological responses, the Company reviewed and analyzed data from a total of 315 patient samples, including 228 patients with varying stages of cancer, as well as blood samples from 87 healthy donors.




KC Holdings Inc. a wholly owned subsidiary of SHOM is working within Kuala Lumpur focusing on healthcare companies in Malaysia

Wed, 07 Dec 2016 06:00:00 EST

NEW YORK, NY and KUALA LUMPUR, MALAYSIA--(Marketwired - Dec 7, 2016) -  Southern Home Medical, Inc. (OTC PINK: SHOM), a technology developer within the healthcare industry, has announced today that KC Holdings, Inc., a wholly owned subsidiary of SHOM, is working within Kuala Lumpur focusing on healthcare in Malaysia. Mr. George Chang, CEO of SHOM, visited Malaysia back in October to meet with Malaysian healthcare officials focusing on improving their technology. These meetings led to the role of KC Holdings, Inc. assisting healthcare companies improve throughout the country while Kuala Lumpur will continue to assist Malaysian healthcare companies' businesses development. This new focus could increase the quality of healthcare for the people of Malaysia in areas such as treatment, safety and detection of health issues.




Zusammenfassung der Forschungspräsentationen bei der 17. Welt-Lungenkrebs-Konferenz der Internationalen Vereinigung für das Studium von Lungenkrebs (International Association for the Study of Lung Cancer, IASLC) am Dienstag, dem 6. Dezember 2016

Wed, 07 Dec 2016 04:58:14 EST

WIEN, ÖSTERREICH--(Marketwired - 7. Dezember 2016) - Die heutige Presseinformation zur 17. Welt-Lungenkrebs-Konferenz (World Conference on Lung Cancer, WCLC) der IASLC setzte den Akzent auf aktive Prävention. Forscher stellten Ergebnisse klinischer Studien vor, die eine Reduzierung des Risikos einer Krankheitsprogression bei Lungenkrebspatienten gezeigt haben. Es stehen Auszüge sowie vollständige Ausgaben der Pressemitteilungen zu jedem behandelten Thema zur Verfügung, darunter der ungekürzte Artikel zur Studie AURA3, der in der heutigen Ausgabe des New England Journal of Medicine erscheint. Weitere Informationen erhalten Sie von Chris Martin, Medienbeauftragter der IASLC, unter cmartin@davidjamesgroup.com.




Resumen de las presentaciones de investigación de la 17ª Conferencia Mundial sobre el Cáncer de Pulmón de la IASLC, martes 6 de diciembre de 2016

Tue, 06 Dec 2016 22:07:17 EST

VIENA, AUSTRIA--(Marketwired - 6 de diciembre de 2016) - La rueda de prensa de hoy en la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) de la IASLC se centró en la prevención activa. Los investigadores compartieron los resultados de ensayos clínicos con medicamentos que han demostrado una reducción del riesgo de progresión de la enfermedad entre pacientes con cáncer de pulmón. Se encuentran disponibles los resúmenes y las versiones completas de los comunicados de prensa sobre cada uno de los temas tratados, incluido el artículo completo sobre el ensayo AURA3 que se publicó hoy en la revista New England Journal of Medicine. Comuníquese con Chris Martin, representante de medios de la IASLC, en cmartin@davidjamesgroup.com para obtener más información.




Résumé des présentations d'études de la 17e Conférence mondiale sur le cancer du poumon de l'IASLC (mardi 6 décembre 2016)

Tue, 06 Dec 2016 20:06:04 EST

VIENNE, AUTRICHE--(Marketwired - 6 décembre 2016) - Le point-presse d'aujourd'hui à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC s'est concentré sur la prévention active, avec des présentations par des chercheurs d'essais cliniques sur des médicaments ayant affiché une réduction du risque de progression de la maladie chez des patients atteints de cancer du poumon. Des résumés et des versions complètes de communiqués de presse pour chaque thème couvert sont disponibles, y compris l'article complet sur l'essai AURA3, qui est publié dans l'édition d'aujourd'hui du New England Journal of Medicine. Pour en savoir plus, veuillez contacter Chris Martin, représentant de l'IASLC auprès des médias, à l'adresse : cmartin@davidjamesgroup.com.




Resumo das Apresentações das Pesquisas na IASLC 17a Conferência Mundial sobre Câncer de Pulmão de terça-feira, dia 6 de dezembro de 2016

Tue, 06 Dec 2016 18:33:12 EST

VIENNA, AUSTRIA--(Marketwired - 6 de dezembro de 2016) - A coletiva com a mídia de hoje na IASLC 17a Conferência Mundial sobre o Câncer de Pulmão (World Conference on Lung Cancer - WCLC) concentrou-se na prevenção ativa, com os pesquisadores compartilhando os resultados dos testes clínicos com medicamentos que demonstraram a redução do risco da progressão da doença nos pacientes com câncer de pulmão. Abstratos e versões completas dos releases de cada tópico estão disponíveis, inclusive o artigo completo sobre o Teste AURA3 publicado hoje no New England Journal of Medicine. Contate Chris Martin, representante de mídia da IASLC no cmartin@davidjamesgroup.com para mais informação.




Winx Sleep Therapy System Now Available Directly to the Millions of Obstructive Sleep Apnea Sufferers Who Can't or Won't Use CPAP

Tue, 06 Dec 2016 10:00:00 EST

REDWOOD CITY, CA--(Marketwired - December 06, 2016) - ApniCure, which makes the Winx Sleep Therapy System for obstructive sleep apnea (OSA), today announces that Winx is now available for direct purchase by consumers. Winx provides relief from obstructive sleep apnea without a mask and is designed specifically for the half of sleep apnea patients who can't or won't use a CPAP (Continuous Positive Airway Pressure) machine. FDA-cleared and previously available only in select sleep labs, Winx is currently available to consumers in California due to initial high demand, but will be available with broader national distribution in 2017.




Wovenware Predicts 2017 is the Year of the Smart App

Tue, 06 Dec 2016 10:00:00 EST

New Year will Increasingly Focus on AI, Chatbots and other Intelligent Tools to Provide More Personalized Customer Experience




Summary of Research Presentations From the IASLC 17th World Conference on Lung Cancer Tuesday, December 6, 2016

Tue, 06 Dec 2016 09:31:06 EST

VIENNA, AUSTRIA--(Marketwired - December 06, 2016) - Today's press briefing at the IASLC 17th World Conference on Lung Cancer (WCLC) focused on active prevention, with researchers sharing results of clinical drug trials that have shown reduction in risk of disease progression among lung cancer patients. Abstracts and full versions of news releases for each topic covered are available, including the complete article on the AURA3 Trial that is published in today's New England Journal of Medicine. Contact IASLC media representative Chris Martin at cmartin@davidjamesgroup.com for more information.




PAC Machinery Introduces Vertrod PS Med Validatable Medical Sealer at PACK EXPO / Pharma EXPO 2016

Tue, 06 Dec 2016 09:30:00 EST

Vertrod PS Medical Impulse Sealer features new MedLogic(TM) controller and interface




LockPath wins 2016 GRC Value Award for IT Governance, Risk Management and Compliance

Tue, 06 Dec 2016 09:00:00 EST

Health IT Company Surescripts Realizes the Benefits of the Keylight Platform




Avaya Solutions Help Leading Medical Supplier Expand Customer Service and Sales

Tue, 06 Dec 2016 09:00:00 EST

Byram Healthcare lays a foundation with Avaya Networking, tops it with Contact Center and Unified Communications applications for higher capacity and cost efficiency




ICTV Brands, Inc. Retail Sales Grow Significantly Entering the Holiday Season

Tue, 06 Dec 2016 08:00:00 EST

WAYNE, PA--(Marketwired - Dec 6, 2016) - ICTV Brands, Inc. (OTCQX: ICTV) (CNSX: ITV), a digitally focused, direct response marketing and branding company specializing in the health, wellness and beauty sector, today announced significant growth in sales of its flagship product DermaWand entering the holiday season.




Fürsprecher der öffentlichen Gesundheit aus aller Welt sagen dem Tabak an weiteren Fronten den Kampf an

Tue, 06 Dec 2016 07:57:29 EST

WIEN, ÖSTERREICH--(Marketwired - 6. Dezember 2016) - Die Bemühungen, Tabak als Gefahr für die öffentliche Gesundheit zu regulieren, haben sich enorm ausgeweitet. Mediziner und Fürsprecher der öffentlichen Gesundheit sind zusammengekommen, um von Tabakunternehmen ausgehende Bedrohungen durch öffentliche Fürsprache, Maßnahmen im Bereich öffentliche Gesundheit sowie Rentenreformen zurückzuschlagen. Bei einer Pressekonferenz im Rahmen der 17. IASLC World Conference on Lung Cancer (WCLC) präsentierten heute Fürsprecher der öffentlichen Gesundheit aus Brasilien, Malaysia, Irland, Australien und Uruguay verschiedene Strategien, mit denen die globale Bedrohung, die von den Tabakunternehmen ausgeht, unter Kontrolle gebracht werden konnte.




Operational Excellence in Immuno-Oncology Clinical Trials, New Webinar Hosted by Xtalks

Tue, 06 Dec 2016 07:30:00 EST

As cancer treatments become more focused on personalized care for the patient, understanding the intricacies of immuno-oncology becomes increasingly important. Join our speakers who will outline how to manage the complexity of these studies and ways to maintain a successful partnership with your CRO




Entrepreneurship 100 concludes inaugural conversation series with a discussion on bringing business ideas to life

Tue, 06 Dec 2016 07:00:00 EST

TORONTO, ON--(Marketwired - December 06, 2016) - On Thursday December 1, 2016 the University of Toronto hosted the final session in the fall series of Entrepreneurship 100: Conversations. The event's panel of entrepreneurs, Christina Cai, co-founder of Knowtions, Hamad Naseem, co-founder of Flarian, and Foteini Agrafioti, co-founder of Nymi, spent the evening answering questions from the audience and spoke about the first steps in founding their businesses.




MDValuate Report Examines Top Reasons Physicians Lose Patients Due to Negative Online Reviews

Tue, 06 Dec 2016 05:30:00 EST

Industry Leader Takes Deep Dive into What Unhappy Patients Are Saying, How to Improve




Des défenseurs de la santé publique du monde entier lancent de nouveaux efforts dans la lutte contre le tabac

Mon, 05 Dec 2016 22:34:26 EST

VIENNE, AUTRICHE--(Marketwired - 5 décembre 2016) - Les efforts visant à contrôler le tabac en tant que menace pour la santé publique se sont intensifiés alors que des médecins et des défenseurs de la santé publique se sont unis afin de repousser les menaces posées par les entreprises de tabac via des actions de sensibilisation, des reformes de pension et de santé publique. Aujourd'hui, des défenseurs de la santé publique provenant du Brésil, de Malaisie, d'Irlande, d'Australie et d'Uruguay ont présenté plusieurs stratégies qui se sont avérées efficaces pour enrayer la menace mondiale posée par les entreprises de tabac lors d'une conférence de presse organisée à l'occasion de la 17e Conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC.




Defensores de Saúde Pública de todo o mundo abrem novas frentes na Guerra Contra o Tabaco

Mon, 05 Dec 2016 19:55:32 EST

VIENNA, AUSTRIA--(Marketwired - 5 de dezembro de 2016) - Os esforços para o controle do tabaco como ameaça à saúde pública intensificaram com a união dos médicos e defensores de saúde no combate às ameaças das empresas de tabaco, por meio da defesa pública, saúde pública e reforma de pensão. Defensores de saúde pública do Brasil, Malásia, Irlanda, Austrália e Uruguai apresentaram estratégias diferentes que têm controlado a ameaça global das empresas de tabaco em uma coletiva com a mídia na IASLC 17a Conferência Mundial sobre o Câncer de Pulmão (World Conference on Lung Cancer - WCLC).




Los defensores de la salud pública mundial abren nuevos frentes en la guerra contra el tabaco

Mon, 05 Dec 2016 19:50:27 EST

VIENA, AUSTRIA--(Marketwired - 5 de diciembre de 2016) - Aumentan los esfuerzos por controlar el tabaco como una amenaza a la salud pública al tiempo que médicos y defensores de la salud pública se unen para volver a vencer las amenazas de las tabacaleras a través de la defensa pública, la salud pública y la reforma de las pensiones. Hoy, los defensores de la salud pública de Brasil, Malasia, Irlanda, Australia y Uruguay presentaron diferentes estrategias que han funcionado efectivamente frente a la amenaza mundial de las tabacaleras en una rueda de prensa celebrada en la 17º Conferencia Mundial sobre el Cáncer de Pulmón (WCLC) de la Asociación Internacional para el Estudio del Cáncer de Pulmón (IASLC).




Arch Therapeutics to Present at 9th Annual LD Micro Main Event on December 7, 2016

Mon, 05 Dec 2016 18:03:42 EST

FRAMINGHAM, MA--(Marketwired - Dec 5, 2016) - Arch Therapeutics, Inc. (OTCQB: ARTH) ("Arch" or the "Company"), developer of the AC5T devices for use in controlling bleeding and fluid loss in order to provide faster and safer surgical and interventional care, today announced that it will be featured as a presenting company at the LD Micro Conference taking place from December 6-8, 2016 at the Luxe Sunset Boulevard Hotel in Los Angeles, California.




Ogilvy CommonHealth Worldwide wins silver at 2016 Clio Health Awards

Mon, 05 Dec 2016 16:33:35 EST

PARSIPPANY, NJ--(Marketwired - Dec 5, 2016) - Ogilvy CommonHealth Worldwide (www.ogilvychww.com), the health behavior change specialists of Ogilvy & Mather (www.ogilvy.com), and a WPP company (NASDAQ: WPPGY) (www.wpp.com), today announced the organization's Sydney-based office, Ogilvy CommonHealth Asia Pacific, has won a silver award at the 2016 Clio Health Awards competition.




InspireMD Announces Change in Presentation Time at LD Micro Main Event Conference to Tuesday, December 6 at 4:30PM PT

Mon, 05 Dec 2016 15:17:39 EST

BOSTON, MA--(Marketwired - Dec 5, 2016) - InspireMD, Inc. (NYSE MKT: NSPR) (NYSE MKT: NSPR.WS) ("InspireMD" or the "Company"), a leader in embolic prevention systems (EPS), neurovascular devices and thrombus management technologies, today announced a change in the Company's presentation time at the LD Micro 9th Annual Main Event on Tuesday, December 6 in Los Angeles, California. Chief Financial Officer, Craig Shore, will now present at 4:30pm PT. Mr. Shore will provide a corporate overview and discuss the Company's proprietary MicroNetT technology, which has been developed to address key issues found with current stenting options.




HIA Supports Efforts to Expand Hearing Aid Use, but Cautions Against "Do It Yourself" Approach

Mon, 05 Dec 2016 14:50:55 EST

WASHINGTON, DC --(Marketwired - December 05, 2016) - The Hearing Industries Association (HIA) supports efforts to increase the accessibility and affordability of hearing aids, but expressed concerns about over the counter (OTC) hearing aids, which would be retailed without essential services including a proper hearing evaluation, fitting and follow-up, potentially putting the hearing health of consumers at risk, the association said in response to new legislation sponsored by Senators Elizabeth Warren (D-MA) and Charles Grassley (R-IA).




BaySand Expands its Global Sales Channel Organization to Support ASIC Designers in Europe, Israel and India

Mon, 05 Dec 2016 14:08:54 EST

TRIAS Mikroelektronik GmbH, Wonderep and Urukrama Semicon will be promoting and supporting BaySand's Metal Configurable Technology




3D Signatures Adds Leading Commercial Diagnostics Lab Executive to Advisory Board

Mon, 05 Dec 2016 12:16:30 EST

WINNIPEG, MB--(Marketwired - December 05, 2016) - 3D Signatures Inc. (TSX VENTURE: DXD) (the "Company" or "3DS") is pleased to announce the appointment of Mr. Nigel Terrett to 3DS' Business Advisory Board ("BAB"). Mr. Terrett will provide the Company with strategic insight and guidance related to commercial lab partnerships and information technology management for its diagnostic platform. Mr. Terrett brings extensive commercial lab experience to 3DS which includes executive roles with several major commercial labs and electronic health record companies such as Excelleris Technologies, Lifelabs Inc. and MDS Diagnostics Inc.




Global Public Health Advocates Open New Fronts in War on Tobacco

Mon, 05 Dec 2016 11:48:27 EST

VIENNA, AUSTRIA--(Marketwired - December 05, 2016) - Efforts to control tobacco as a public health threat have escalated as clinicians and public health advocates have coalesced to beat back threats from tobacco companies through public advocacy, public health, and pension reform. Today, public health advocates from Brazil, Malaysia, Ireland, Australia, and Uruguay presented different strategies that have effectively reigned in the global threat of tobacco companies at a press briefing held at IASLC 17th World Conference on Lung Cancer (WCLC).




Advantis Corp. Acquires Rights to Nugsmasher Line of Rosin Presses

Mon, 05 Dec 2016 09:26:00 EST

NEWPORT BEACH, CA--(Marketwired - Dec 5, 2016) - ADVANTIS CORPORATION (OTC PINK: ADVT), announced that it has acquired rights to be the exclusive distributor and 25% owner of the Nugsmasher line of rosin presses.




Pacific Safety Products Inc. receives unsolicited offer of $0.25 per share from MKU Limited

Mon, 05 Dec 2016 09:19:59 EST

ARNPRIOR, ONTARIO--(Marketwired - Dec. 5, 2016) - Pacific Safety Products Inc. ("PSP" or the "Company") (TSX VENTURE:PSP), a leading North American manufacturer of advanced armour and personal protection solutions, announced today that it has received an unsolicited offer from an affiliate of MKU Limited ("MKU") to acquire all of the outstanding common shares of PSP, including those issuable upon conversion of PSP's outstanding convertible debentures, for $0.25 in cash per share (the "MKU Offer"). The Board of Directors of PSP (the "Board") is, together with if financial advisor and legal counsel, reviewing the MKU Offer to determine whether it constitutes a "Superior Proposal" as defined in the arrangement agreement between PSP and Med-Eng Holdings ULC, a Canadian wholly-owned subsidiary of Safariland, LLC ("Safariland"), announced on November 10, 2016 (the "Safariland Agreement") and has provided notice of such review to Safariland. At this time, the Board has not changed its recommendation with respect to the pending transaction with Safariland. In order to constitute a Superior Proposal pursuant to the Arrangement Agreement, among other conditions, the Board must determine that the MKU Offer is reasonably capable of being completed without undue delay, taking into account all financial, legal, regulatory and other aspects of the MKU Offer and MKU.




SYSPRO Canada Customer, Daiya Foods, Wins Best Consumer Product at 2016 BC Export Awards

Mon, 05 Dec 2016 09:00:00 EST

The province's most prestigious awards pay tribute to the success and innovative approaches of BC export companies




Align Technology Announces 2017 Research Award Program

Mon, 05 Dec 2016 09:00:00 EST

Up to $300,000 Available in Funding for Dental Research Grants




Full Enrollment Reached in Tactile Communication and Neurorehabilitation Laboratory Clinical Trial

Mon, 05 Dec 2016 09:00:00 EST

Investigating PoNS(TM) Therapy for the Treatment of Chronic Balance Deficit Due to Mild-to-Moderate Traumatic Brain Injury (TBI)




BriaCell to Present at a Breast Cancer Symposium, and Enters into a Research Agreement with Terasaki Foundation Laboratory

Mon, 05 Dec 2016 08:30:00 EST

BERKELEY, CA and VANCOUVER, BC--(Marketwired - December 05, 2016) - BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX VENTURE: BCT) (OTCQB: BCTXF), a clinical-stage company dedicated to the development of immuno-oncology treatments, today announced that the Company will present the latest development update for BriaVaxT, the Company's proprietary vaccine for advanced breast cancer, at the 39th Annual San Antonio Breast Cancer Symposium in San Antonio, Texas. Additionally, the Company signed a service agreement contract with the Terasaki Foundation Laboratory, a leading non-profit research institution in the area of organ transplantation and immunology, based in Los Angeles.




HCi Viocare enters into discussions with New Balance Athletics, Inc.

Mon, 05 Dec 2016 08:27:07 EST

GLASGOW, SCOTLAND--(Marketwired - Dec 5, 2016) - HCi Viocare (OTCQB: VICA), is pleased to announce that it has entered into discussions with one of the major sport shoes manufacturers in the world, New Balance Athletics, Inc.




Aurora Spine Launches Mobile App

Mon, 05 Dec 2016 08:24:59 EST

CARLSBAD, CALIFORNIA--(Marketwired - Dec. 5, 2016) - Aurora Spine Corporation (TSX VENTURE:ASG) announced today the launch of its new Aurora Spine Mobile App, designed to bring information regarding the new and exciting products being offered by Aurora Spine straight to your mobile device. The App is currently available for Apple, Android, and iPad devices.




Spectral Announces Appointment of Dr. Masayuki Kaneko to Its Board of Directors

Mon, 05 Dec 2016 08:00:00 EST

TORONTO, ONTARIO--(Marketwired - Dec. 5, 2016) - Spectral Medical Inc. ("Spectral" or the "Company") (TSX:EDT) (OTCQX:EDTXF) a Phase III company developing the first treatment for patients with endotoxemic septic shock using a medical device, today announced the appointment of Dr. Masayuki Kaneko as the Toray Industries, Inc. ("Toray") representative on its Board of Directors.




Aktiver Wissensaustausch und Gesundheitsvorsorgemodelle in Gemeinden ergänzen Forschung und klinische Pflege ? darüber wurden sich weltweite Experten in Wien (Österreich) auf der von der Internationalen Vereinigung für das Studium von Lungenkrebs veranstal

Sun, 04 Dec 2016 20:14:05 EST

WIEN, ÖSTERREICH--(Marketwired - 4. Dezember 2016) - Lungenkrebsforscher und Patientenvertreter aus aller Welt betonten heute, dass neue Behandlungsmodelle sowie der aktive Wissensaustausch über Krebsbehandlungsmöglichkeiten eine wichtige Rolle bei der Bekämpfung von Lungenkrebs spielen. Diese Aussage wurde am ersten Tag der von der IASLC veranstalteten 17. Welt-Lungenkrebs-Konferenz (World Conference on Lung Cancer, WCLC) in Wien (Österreich) verlautet.




Les experts mondiaux de la recherche et des soins cliniques complémentaires relatifs aux modèles de soins médicaux associatifs et communautaires se réunissent à Vienne, en Autriche, à l'occasion de la dix-septième édition de la Conférence mondiale sur le c

Sun, 04 Dec 2016 20:04:23 EST

VIENNE, AUTRICHE--(Marketwired - 4 décembre 2016) - Un groupe composé de chercheurs et de membres d'associations de défense des patients atteints de cancer du poumon a souligné aujourd'hui que les nouveaux modèles de prestation et de communication des soins relatifs au cancer jouaient un rôle important dans la lutte contre cette forme de pathologie cancéreuse. Leurs observations ont été émises lors de la première journée de la 17e conférence mondiale sur le cancer du poumon (WCLC) de l'IASLC, organisée dans la capitale autrichienne.




Modelos de defensa y atención sanitaria a la comunidad complementan la investigación y la atención clínica; expertos mundiales se congregan en Viena, Austria, en la 17 Conferencia Mundial sobre Cáncer de Pulmón Mundial de la Asociación Internacional para e

Sun, 04 Dec 2016 19:23:53 EST

VIENA, AUSTRIA--(Marketwired - 4 de diciembre de 2016) - Investigadores y defensores de pacientes con cáncer de pulmón de todo el mundo enfatizaron hoy que los nuevos modelos de prestación de atención y comunicación en la atención oncológica desempeñan un papel importante en la lucha contra el cáncer de pulmón. Estos son los comentarios del primer día de la 17ª Conferencia Mundial sobre Cáncer de Pulmón (WCLC) (WCLC) que tiene lugar en Viena, Austria.




Modelos de Defesa de Cuidado de Saúde Comunitário complementam a Convenção de Experts Mundiais de Pesquisa e Cuidado Clínico em Viena, Áustria da 17a. Conferência Mundial de Câncer de Pulmão da International Association for the Study of Lung Cancer

Sun, 04 Dec 2016 15:58:15 EST

VIENNA, AUSTRIA--(Marketwired - 4 de dezembro de 2016) - Pesquisadores e defensores de pacientes de câncer de pulmão de todo o mundo enfatizam que os novos modelos de cuidado e de comunicação sobre o câncer de pulmão têm um papel importante na luta contra o câncer de pulmão. Esta observação foi feita no primeiro dia da IASLC 17th World Conference on Lung Cancer (Conferência Mundial de Câncer de Pulmão - WCLC) em Viena, Áustria.




Advocacy and Community Health Care Models Complement Research and Clinical Care World Experts Convene in Vienna, Austria at the International Association for the Study of Lung Cancer 17th World Conference on Lung Cancer

Sun, 04 Dec 2016 07:52:09 EST

VIENNA, AUSTRIA--(Marketwired - December 04, 2016) - Global lung cancer researchers and patient advocates today emphasized that new models of delivering care and communicating about cancer care play an important role in the fight against lung cancer. Their remarks come on the first day of the IASLC 17th World Conference on Lung Cancer (WCLC) in Vienna, Austria.




Starkey(R) Hearing Technologies, uno de los fabricantes más importantes de auxiliares auditivos a nivel mundial, lanza una y revolucionaria tecnología en el marco de la celebración del XV Aniversario de su Oficina en la Ciudad de México

Sat, 03 Dec 2016 09:00:00 EST

CIUDAD DE MÉXICO, MÉXICO--(Marketwired - 3 de diciembre de 2016) - Starkey S.A de C.V., filial en La República Mexicana de la compañía de soluciones auditivas líder a nivel mundial, Starkey® Hearing Technologies, celebrará este sábado 3 de diciembre El Decimoquinto Aniversario de sus oficinas en la Ciudad de México, contando con la presencia de su Fundador y Presidente Ejecutivo Sr. William F. Austin, quien fue reconocido en 2010 por el ex Presidente de México Lic. Felipe Calderón con la Orden del Águila Azteca en Grado de Insignia, así como la cantante y filántropa zambiana Portia Clark.




Inicia Conferencia Internacional sobre el Cáncer de Pulmón, presenta avances decisivos en la investigación del cáncer de pulmón y la salud pública

Sat, 03 Dec 2016 04:00:00 EST

VIENA, AUSTRIA--(Marketwired - 3 de diciembre de 2016) - La Asociación Internacional del Estudio del Cáncer de Pulmón (IASLC) inicia la IASLC 17ava. Conferencia Mundial del Cáncer de Pulmón (WCLC) mañana, el principal encuentro mundial dedicado al cáncer de pulmón y otras malignidades torácicas. La IASLC 17ava. WCLC cubrirá todos los aspectos sobre el control de los cánceres de pulmón, mesotelioma, carcinoma tímico, y otras malignidades torácicas. Más de 6.000 investigadores, médicos, especialistas, enfermeras, activistas y pacientes asistirán para obtener mayor información acerca de los avances en la investigación y ensayos clínicos del cáncer de pulmón en todo el mundo. La IASLC 17ava. WCLC se realiza en el Messe Wien Exhibition & Congress Center en Viena, Austria, del 4 al 7 de diciembre de 2016.




Conferência Mundial da Associação Internacional de Estudo de Câncer de Pulmão tem início compartilhando os principais avanços de pesquisa e saúde pública do câncer de pulmão

Sat, 03 Dec 2016 04:00:00 EST

VIENNA, AUSTRIA--(Marketwired - 3 de dezembro de 2016) - The International Association for the Study of Lung Cancer (IASLC) dará início a IASLC 17th World Conference on Lung Cancer (WCLC) amanhã, realizando a maior conferência dedicada ao câncer de pulmão e outras doenças malignas do tórax. A IASLC 17th WCLC abrangerá todos os aspectos da gestão de câncer de pulmão, mesotelioma, tímica e outras malignidades torácicas. Mais de 6.000 pesquisadores, médicos, especialistas, enfermeiros, defensores e pacientes participarão do evento para saber mais sobre os avanços na pesquisa e testes clínicos de câncer de pulmão em todo o mundo. A IASLC 17th WCLC será realizada na Messe Wien Exhibition & Congress Center em Viena, Áustria entre 4-7 de dezembro de 2016.




International Conference on Lung Cancer Research Kicks Off; Key Advances in Lung Cancer Research and Public Health to be Shared

Sat, 03 Dec 2016 04:00:00 EST

VIENNA, AUSTRIA--(Marketwired - December 03, 2016) - The International Association for the Study of Lung Cancer (IASLC) kicks off the IASLC 17th World Conference on Lung Cancer (WCLC) tomorrow, the world's largest meeting dedicated to lung cancer and other thoracic malignancies. The IASLC 17th WCLC will cover all aspects of the management of lung cancers, mesothelioma, thymic, and other thoracic malignancies. More than 6,000 researchers, physicians, specialists, nurses, advocates, and patients will be in attendance to learn more about advancements in lung cancer research and clinical trials across the globe. The IASLC 17th WCLC takes place at the Messe Wien Exhibition & Congress Center in Vienna, Austria Dec. 4-7, 2016.




Coup d'envoi de la Conférence internationale pour la recherche sur le cancer du poumon : de grandes avancées en matière de recherche et de programmes de santé publique sur le cancer du poumon seront communiquées

Sat, 03 Dec 2016 04:00:00 EST

VIENNE, AUTRICHE--(Marketwired - 3 décembre 2016) - L'Association internationale pour l'étude du cancer du poumon (IASLC) donne demain le coup d'envoi de la 17ème conférence WCLC (World Conference on Lung Cancer), le plus vaste colloque au monde consacré au cancer du poumon et aux autres tumeurs thoraciques. Au cours de sa 17ème édition, la WCLC couvrira tous les aspects liés à la prise en charge du cancer du poumon, des mésothéliomes, des tumeurs du thymus et des autres tumeurs thoraciques. Plus de 6 000 chercheurs, médecins, spécialistes, personnels infirmiers, militants et patients y participeront afin d'en apprendre davantage sur les avancées de la recherche sur le cancer du poumon et sur les essais cliniques réalisés à travers le monde. La 17ème conférence WCLC se tiendra au centre d'exposition et de conférence de Vienne (Messe Wien), en Autriche, du 4 au 7 décembre 2016.




Internationale Konferenz zur Lungenkrebsforschung startet; es wird über wichtige Fortschritte bei der Lungenkrebsforschung und Volksgesundheit berichtet

Sat, 03 Dec 2016 04:00:00 EST

WIEN, ÖSTERREICH--(Marketwired - 3. Dezember 2016) - The International Association for the Study of Lung Cancer (die Internationale Gesellschaft für das Studium von Lungenkrebs, IASLC) läutet morgen die 17. IASLC-Weltkonferenz zu Lungenkrebs (WCLC) ein, die weltweit größte Tagung zu Lungenkrebs und anderen thorakalen Tumoren. Die 17. IASLC-WCLC deckt alle Aspekte des Umgangs mit Lungenkrebs, Mesotheliom, Thymus- und anderen thorakalen Tumoren ab. Mehr als 6.000 Forscher, Ärzte, Spezialisten, Krankenschwestern, Rechtsanwälte und Patienten werden teilnehmen, um mehr über die Fortschritte in der Lungenkrebsforschung und über klinische Studien auf der ganzen Welt zu erfahren. Die 17. IASLC-WCLC findet im Ausstellungs- und Kongresszentrum "Messe Wien" in Wien vom 4. bis 7. Dezember 2016 statt.




Simavita releases unaudited financial statements and MD&A for the three-month period ended September 30, 2016

Fri, 02 Dec 2016 14:35:41 EST

SYDNEY, AUSTRALIA--(Marketwired - Dec. 2, 2016) - Simavita Limited ("Simavita" or the "Company") (ASX:SVA), is refiling its financial results in accordance with Canadian reporting requirements for the first quarter ended September 30, 2016.




BrainChip and Cisco Internet of Everything Innovation Center Sign Agreement to Demonstrate the Capabilities of BrainChip's Spiking Neural Adaptive Processor (SNAP) Technology

Fri, 02 Dec 2016 13:05:50 EST

Highlights: BrainChip signs an agreement with the Cisco Internet of Everything Innovation Center to demonstrate BrainChip's SNAP technology; The first demonstration will commence in December of 2016 and showcase traffic monitoring and advanced analysis capabilities; A second demonstration focusing on an in-vehicle camera for hazard detection and road safety is also being developed as part of the agreement




Radius Bank Announces Acquisition of Equipment Finance Division

Fri, 02 Dec 2016 10:53:02 EST

Bank expands commercial lending with new product offering




Containing Hazardous Drugs with CSTDs Focus of B. Braun Medical CE Symposium at ASHP

Fri, 02 Dec 2016 10:00:00 EST

BETHLEHEM, PA--(Marketwired - Dec 2, 2016) - Experts will present a panel discussion on "Understand the Evidence and Requirements from USP < 800 > to the NIOSH Universal Testing Draft Protocol" at a B. Braun Medical Inc. sponsored symposium during the American Society of Health-System Pharmacists (ASHP) 51st Midyear Clinical Meeting. The symposium for continuing education credits will be held on Tuesday, Dec. 6, from 11:30 a.m. to 1:00 p.m. at the South Pacific J North Convention Center at Mandalay Bay in Las Vegas.




VigiLanz Antimicrobial Stewardship Solutions Reduce Medication and Antimicrobial Expenditures, Drive Compliant Reporting at Leading Health Systems

Fri, 02 Dec 2016 10:00:00 EST

VigiLanz will highlight its antimicrobial stewardship offerings at the ASHP 2016 Midyear Clinical Meeting & Exhibition (Booth #1843)